We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.36B
AUM Growth
-$139M
Cap. Flow
-$13.7M
Cap. Flow %
-0.58%
Top 10 Hldgs %
14.94%
Holding
439
New
27
Increased
142
Reduced
196
Closed
28

Top Sells

Rank Stock Value
1
PSB
PS Business Parks, Inc.
PSB
+$14.8M
2
LNC icon
Lincoln National
LNC
+$6.57M
3
DLB icon
Dolby
DLB
+$5.42M
4
CME icon
CME Group
CME
+$5.16M
5
HUBG icon
HUB Group
HUBG
+$4.91M

Sector Composition

Rank Sector Weight
1 Technology 19.1%
2 Financials 16.62%
3 Healthcare 12.69%
4 Industrials 11.61%
5 Consumer Discretionary 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
426
Teradyne
TER
$57.5B
-4,902
Closed -$439K
MAGN
427
Magnera Corp
MAGN
$458M
-47,603
Closed -$4.26M
RADI
428
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
-109,300
Closed -$1.67M
TPTX
429
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-9,784
Closed -$736K
PSB
430
DELISTED
PS Business Parks, Inc.
PSB
-78,855
Closed -$14.8M
SBNY
431
DELISTED
Signature Bank
SBNY
-5,571
Closed -$998K
BHVN
432
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-10,741
Closed -$1.56M

Similar funds

Chartwell Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Chartwell Investment Partners held 439 positions worth $2.36B, down 5.6% from $2.49B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Chartwell Investment Partners's Q3 2022 filing shows 27 new, 142 increased, 196 reduced and 28 closed positions. Its largest new stake was AdaptHealth: 517,839 shares worth $9.72M. The largest sale was PS Business Parks, Inc., an estimated $14.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q3 2022 buy was AdaptHealth: 517,839 shares worth $9.72M.
  • Chartwell Investment Partners added most to Eli Lilly in Q3 2022, an estimated $7.67M increase.
  • Chartwell Investment Partners's biggest Q3 2022 reduction was Lincoln National, cutting an estimated $6.57M.
  • Chartwell Investment Partners fully exited PS Business Parks, Inc. in Q3 2022, selling an estimated $14.8M.
  • Chartwell Investment Partners's ten largest holdings make up 15% of its $2.36B portfolio in Q3 2022.
  • Chartwell Investment Partners opened 27 new positions and closed 28 in Q3 2022.
  • Chartwell Investment Partners's portfolio value fell 5.6% quarter-over-quarter to $2.36B.

Based on Chartwell Investment Partners's 13F filing for Q3 2022, filed 27 Oct 2022.